129 related articles for article (PubMed ID: 1704266)
1. An epitope on the transferrin receptor preferentially exposed during tumor progression in human lymphoma is close to the ligand binding site.
Takahashi S; Esserman L; Levy R
Blood; 1991 Feb; 77(4):826-32. PubMed ID: 1704266
[TBL] [Abstract][Full Text] [Related]
2. An epitope of the transferrin receptor is exposed on the cell surface of high-grade but not low-grade human lymphomas.
Esserman L; Takahashi S; Rojas V; Warnke R; Levy R
Blood; 1989 Dec; 74(8):2718-29. PubMed ID: 2479430
[TBL] [Abstract][Full Text] [Related]
3. Disparity between expression of transferrin receptor ligand binding and non-ligand binding domains on human lymphocytes.
Boldt DH; Phillips JL; Alcantara O
J Cell Physiol; 1987 Aug; 132(2):331-6. PubMed ID: 3624319
[TBL] [Abstract][Full Text] [Related]
4. Correlation of transferrin receptor expression with histological class and outcome in non-Hodgkin lymphoma.
Habeshaw JA; Lister TA; Stansfeld AG; Greaves MF
Lancet; 1983 Mar; 1(8323):498-501. PubMed ID: 6131211
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibody PAL-M1 recognizes the transferrin receptor and is a progression marker in melanocytic lesions.
van Muijen GN; Ruiter DJ; Hoefakker S; Johnson JP
J Invest Dermatol; 1990 Jul; 95(1):65-9. PubMed ID: 2366002
[TBL] [Abstract][Full Text] [Related]
6. Transferrin receptor expression by non-Hodgkin's lymphomas. Correlation with morphologic grade and survival.
Medeiros LJ; Picker LJ; Horning SJ; Warnke RA
Cancer; 1988 May; 61(9):1844-51. PubMed ID: 3355978
[TBL] [Abstract][Full Text] [Related]
7. Characterization of a novel form of transferrin receptor preferentially expressed on normal erythroid progenitors and precursors.
Cotner T; Gupta AD; Papayannopoulou T; Stamatoyannopoulos G
Blood; 1989 Jan; 73(1):214-21. PubMed ID: 2462936
[TBL] [Abstract][Full Text] [Related]
8. Development of human single-chain antibodies to the transferrin receptor that effectively antagonize the growth of leukemias and lymphomas.
Crépin R; Goenaga AL; Jullienne B; Bougherara H; Legay C; Benihoud K; Marks JD; Poul MA
Cancer Res; 2010 Jul; 70(13):5497-506. PubMed ID: 20530676
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneity of the human transferrin receptor and use of anti-transferrin receptor antibodies to detect tumours in vivo.
Panaccio M; Zalcberg JR; Thompson CH; Leyden MJ; Sullivan JR; Lichtenstein M; McKenzie IF
Immunol Cell Biol; 1987 Dec; 65 ( Pt 6)():461-72. PubMed ID: 2452131
[TBL] [Abstract][Full Text] [Related]
10. Transferrin receptor induction in mitogen-stimulated human T lymphocytes is required for DNA synthesis and cell division and is regulated by interleukin 2.
Neckers LM; Cossman J
Proc Natl Acad Sci U S A; 1983 Jun; 80(11):3494-8. PubMed ID: 6304712
[TBL] [Abstract][Full Text] [Related]
11. A transferrin receptor antibody represents one signal for the induction of IL 2 production by a human T cell line.
Manger B; Weiss A; Hardy KJ; Stobo JD
J Immunol; 1986 Jan; 136(2):532-8. PubMed ID: 3001178
[TBL] [Abstract][Full Text] [Related]
12. Plasma membrane and intracellular pools of transferrin receptors decline during in vitro cultivation of U937 cells.
Salcedo TW; Fleit HB
Cell Prolif; 1991 Jul; 24(4):383-401. PubMed ID: 1863677
[TBL] [Abstract][Full Text] [Related]
13. Structural features of the cell surface receptor for transferrin that is recognized by the monoclonal antibody OKT9.
Schneider C; Sutherland R; Newman R; Greaves M
J Biol Chem; 1982 Jul; 257(14):8516-22. PubMed ID: 6282884
[TBL] [Abstract][Full Text] [Related]
14. Identification of the epitope of a monoclonal antibody that disrupts binding of human transferrin to the human transferrin receptor.
Teh EM; Hewitt J; Ung KC; Griffiths TA; Nguyen V; Briggs SK; Mason AB; MacGillivray RT
FEBS J; 2005 Dec; 272(24):6344-53. PubMed ID: 16336271
[TBL] [Abstract][Full Text] [Related]
15. Immunological and biochemical characterization of an epitope of the transferrin receptor involved in the production of interferon-gamma and B-cell growth factor.
Suciu-Foca N; Rosochacki SJ; Cai J; Reed E; Rubinstein P; King DW
Cell Immunol; 1987 Dec; 110(2):265-81. PubMed ID: 2446777
[TBL] [Abstract][Full Text] [Related]
16. Expression of three cell proliferation-associated antigens, DNA polymerase alpha, Ki-67 antigen and transferrin receptor in nodal and cutaneous T-cell lymphomas.
Mitani S; Tango T; Sonobe Y; Baba N; Nagatani T; Nomoto S; Mori S
Int J Hematol; 1991 Oct; 54(5):385-93. PubMed ID: 1756249
[TBL] [Abstract][Full Text] [Related]
17. Characterization of a new monoclonal antibody (TR-19) against human transferrin receptor and its application in topographic study.
Poláková K; Karpatová M
Neoplasma; 1991; 38(1):21-31. PubMed ID: 2011206
[TBL] [Abstract][Full Text] [Related]
18. Exposure of K562 cells to anti-receptor monoclonal antibody OKT9 results in rapid redistribution and enhanced degradation of the transferrin receptor.
Weissman AM; Klausner RD; Rao K; Harford JB
J Cell Biol; 1986 Mar; 102(3):951-8. PubMed ID: 3005341
[TBL] [Abstract][Full Text] [Related]
19. Cytosine arabinoside increases the binding of 125I-labelled epidermal growth factor and 125I-transferrin and enhances the in vitro targeting of human tumour cells with anti-(growth factor receptor) mAb.
Caraglia M; Tagliaferri P; Correale P; Genua G; Pinto A; Del Vecchio S; Esposito G; Bianco AR
Cancer Immunol Immunother; 1993 Aug; 37(3):150-6. PubMed ID: 8392910
[TBL] [Abstract][Full Text] [Related]
20. Do monoclonal antibodies Tü15 and Tü67 detect heterogeneity of human transferrin receptor molecules?
Uchańska-Ziegler B; Wernet P; Liangru S; Ziegler A
FEBS Lett; 1984 Oct; 175(2):279-83. PubMed ID: 6207050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
